Abstract:Protein kinase C iota (PKC iota) is an atypical PKC isoform and participates in multiple aspects of the transformed phenotype in human cancer cells. We previously reported that frequent amplification and overexpression of PKC iota were correlated with lymph node metastasis in primary esophageal squamous cell carcinomas (ESCC). In the present study, short interfering RNA-mediated silencing of PKC iota revealed that this enzyme was required for cell migration, invasion, and resistance to anoikis. In vivo experiments showed that PKC iota suppression decreased tumor growth in esophageal cancer xenografts and lung metastases in nude mice. At the molecular level, knockdown of PKC iota in suspended ESCC cells caused a decrease in S-phase kinase-associated protein 2 (SKP2) that had been reported to promote resistance to anoikis via the PI3K/AKT pathway. AKT phosphorylation was abolished after PKC iota suppression, but AKT activation could be refreshed by PKC iota upregulation, suggesting that PKC iota enhanced cell resistance to anoikis via the PKC iota-SKP2-PI3K/AKT pathway. Addition of the proteasome inhibitor MG132 prevented the decrease of SKP2 in PKC iota silenced cells, and polyubiquitin-SKP2 was elevated after PKC iota depletion, showing that PKC iota might regulate the expression of SKP2 through the ubiquitin-proteasome pathway in suspended cells. Furthermore, overexpression of SKP2 in PKC iota-downregulated cells restored cell resistance to anoikis. Most importantly, PKC iota expression significantly correlated with SKP2 in 133 ESCC tissues (P 0.031). Taken together, our data show that PKC iota promotes tumorigenicity and metastasis of human esophageal cancer and that SKP2 is a candidate downstream effector of PKC iota signaling in ESCC. Mol Cancer Res; 9(4); 390-402. (C) 2011 AACR.

Atypical Protein Kinase C Iota (Pkc Iota) Promotes Metastasis Of Esophageal Squamous Cell Carcinoma By Enhancing Resistance To Anoikis Via Pkc Iota-Skp2-Akt Pathway